Skip to content

Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera

Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera According to Conditions of Examination Execution: Assessment of Infarction or Ischemia, Injected Dye and Sequence of Injections

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02861235
Acronym
DSPECT
Enrollment
276
Registered
2016-08-10
Start date
2009-11-30
Completion date
2010-05-31
Last updated
2016-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia, Myocardial Infarction

Brief summary

Myocardial perfusion tomoscintigraphy is a routine medicine procedure to check for the presence and severity of abnormalities of myocardial perfusion, as well as the extension of infarction residua. However, actual imagery devices (gamma cameras) have low resolution and detection sensitivity. A new semiconductor camera has 8 to 10 time higher detection sensitivity and could allow proportionally diminishing injected activities or recording times. Only one pilot study has been recently published on this type of camera, the D.SPECT camera. This study will compare images recorded during 15 to 20 minutes by conventional cameras and 2 to 4 minutes by D.SPECT camera in patients doing tomoscintigraphy under usual conditions. The purpose is to demonstrate the equivalence of images recorded by two camera types for diagnostic information and the secondary purpose is to demonstrate the superiority of the D.SPECT camera in terms of image quality.

Detailed description

This study will be conducted in Nuclear Medicine departments (Nancy Hospital, Bichat Hospital in Paris, Pasteur private hospital in Toulouse), with D.SPECT camera (Cyclopharma). The D.SPECT camera recording will be realized following the conventional camera recording and will not modify the routine programmed examination. Recording times of D.SPECT camera will be maximum 2 minutes for imaging with a strong activity of technetium-99m labeled dye and maximum 4 minutes for imaging with thallium-201 or with a low activity of technetium-99m labeled dye.6 study groups will be analyzed: 4 groups of patients initially doing stress tomoscintigraphy with thallium-201 (group 1) or with technetium-99m labeled dye and then testing 3 principal injection sequences (group 2, 3, 4), and 2 groups of patients initially doing myocardial viability assessment with rest tomoscintigraphy with thallium-201 (group 5) or technetium-99m labeled dye. Recording comparison obtained with 2 cameras will be done according to qualitative and quantitative criteria on image quality and analyzing diagnosis concordance (presence, type and severity of observed abnormalities).

Interventions

OTHERStress thallium-201 tomoscintigraphy, followed by a second rest tomoscintigraphy if necessary

with gamma-camera and D.SPECT camera

OTHERRest technetium-99m tomoscintigraphy followed by stress technetium-99m tomoscintigraphy on the same day

with gamma-camera and D.SPECT camera, in Toulouse centre

OTHERStress technetium-99m tomoscintigraphy followed by rest technetium-99m tomoscintigraphy on the same day

with gamma-camera and D.SPECT camera, in Nancy centre

OTHERstress technetium-99m tomoscintigraphy followed by rest technetium-99m tomoscintigraphy in two different days

with gamma-camera and D.SPECT camera, in Paris centre

OTHERRest thallium-201 tomoscintigraphy with gamma-camera and D.SPECT camera

rest thallium-201 tomoscintigraphy for myocardial viability assessment

OTHERRest technetium-99m tomoscintigraphy with gamma-camera and D.SPECT camera

rest technetium-99m tomoscintigraphy for myocardial viability assessment

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Understanding and signature of informed consent * Without any contraindication for tomoscintigraphy and stress techniques according to French Society of Cardiology and Nuclear Medicine criteria, as established for all patients doing this routine examination * Not in emergency situation and with a stable clinical status (without any sign of heart or coronary failure, without uncontrolled high blood pressure under treatment) * Having an effective contraception for women of childbearing potential

Exclusion criteria

* Patient under guardianship

Design outcomes

Primary

MeasureTime frame
Ejection fraction of link ventricleday 0
Telesystolic volume of link ventricleday 0
Area of damaged regions of heartday 0
Telediastolic volume of link ventricleday 0
Diagnosis of stress ischemia with Myocardial Tomoscintigraphy dataday 0

Secondary

MeasureTime frame
Global myocardial activityday 0
Qualitative score of image qualityday 0

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026